Developed by:
Johnson & Johnson (USA)

Objective:
To measure frequency, severity, degree of bother for GERD symptoms

Copyright:
Johnson & Johnson, USA. All rights reserved.

Reference publication:
Rothman M, Farup C, Stewart W, Helbers L, Zeldis J. Symptoms associated with gastroesophageal reflux disease - Development of a questionnaire for use in clinical trials. Dig-Dis-Sci 2001;46(7):1540-8

Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions required by the Authors are detailed.

2. Distribution Fees:

Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge

- In funded academic research (2): 300 €* per study + an additional 50 €* per language version requested.

- In commercial studies (3) involving "for-profit" organizations: 600 €* per study + an additional 250 €* per language-version requested.

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).


Review copy:  

Original US English version available for review purpose only. Please click here to access.

Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.

More information on GSAS on PROQOLID

[ BACK ]